TRANSFORM national prostate cancer screening trial
TRANSFORM is designed to find the best way to screen men for prostate cancer, so one day, all men at risk are invited for regular tests to find aggressive cancers in time for a cure.
It will revolutionise diagnosis by testing the most promising screening techniques available, including PSA blood tests, genetic tests and fast MRI scans, combined in ways that have never before been tested in a large-scale screening trial.
TRANSFORM will compare multiple screening options to each other, and the current system, to find the safest, most accurate and most cost-effective way to screen men for prostate cancer.
Read more
Misconceptions and myths about prostate cancer are common and can prevent men from seeking timely advice, screening, or treatment.
Addressing these myths is crucial to improving early detection and outcomes.
The West Midlands Cancer Alliance has created downloadable “Myths vs. Reality” infographics for you to use.
These resources can be displayed within your practice, used to support staff, or printed and shared with patients.
Effectively identifying patients at increased risk of prostate cancer is crucial to improving early detection and outcomes, particularly for populations historically underrepresented.
Effective patient engagement is a key part of increasing early detection of prostate cancer, particularly in high-risk populations such as Black men. Sending targeted text messages allows practices to reach patients directly, raising awareness and prompting action without the need for an initial GP appointment.